MED-EL USA: Military ENT Physicians, Travel and Minimal-Work Honoraria

In the MED-EL USA military physician settlement, the hearing-device maker agreed to pay $494,951 to the U.S. Army and U.S. Navy over allegations that it used meals, overseas travel and honoraria requiring little or no work to influence military physicians’ device choices. The alleged campaign reached the specialists who chose what to implant. For someone inside device sales, the important connection is between what the physician received personally and what the military bought for its patients.

The Justice Department’s settlement announcement described MED-EL USA as a Durham, North Carolina manufacturer and seller of cochlear implants and other hearing devices, and a subsidiary of Austrian-based MED-EL.

What MED-EL Allegedly Offered Military ENTs

The government alleged that MED-EL ran a deliberate campaign from 2010 through 2013 to increase use of its products in Defense Department medical facilities. It targeted an Army ear, nose and throat specialist at Madigan Army Medical Center in Tacoma, Washington, and a Navy specialist at the San Diego Naval Medical Center in California.

According to the government’s account, the company offered free meals, overseas travel opportunities and honoraria requiring little or no actual work. The intended return was influence over the physicians’ choice of hearing devices.

The Physician Chose and the Military Bought

Implant sales can depend on a physician’s preference even when an institution pays the bill. The Department of Health and Human Services’ Office of Inspector General, in its alert on physician-owned entities, describes implantable devices as physician preference items because physicians may make or strongly influence both the brand and type selected. The hospital or surgery center is the institutional buyer.

The alleged MED-EL campaign targeted that gap between the person choosing the device and the institution paying for it. The alleged personal benefit went to the chooser. The government was the customer.

The military setting also sharpened the patient-care concern. The Justice Department emphasized the government’s obligation to provide quality health care to service members and their families. Its point was direct: patients should receive the device best suited to their condition, while a free trip or meal gives the physician a separate reason to favor a manufacturer. The alleged sales strategy put that private benefit inside a healthcare decision made for a patient.

Military Sales During the Alleged Campaign

The government’s announcement placed the military sales increase alongside the benefits received by the two specialists.

The Settlement and the Sales Consultant

The Justice Department announced the civil settlement on February 13, 2015.

MED-EL admitted no wrongdoing in the settlement. The announcement also reported that MED-EL dismissed its former chief operating officer and terminated its relationship with the external sales consultant who, according to the government, orchestrated the alleged improper payments scheme.

Why Minimal-Work Honoraria Matter

The honoraria allegation connects the fee to the product choice through the work the physician was expected to perform. If a fee required almost no work, the commercial value alleged here was the physician’s influence over hearing-device selection. That is why the assignment behind a payment matters as much as its accounting label.

The Justice Department pointed to the Anti-Kickback Statute and the False Claims Act as laws addressing payments intended to influence physicians’ medical decisions. Here, the alleged inducements were aimed at the doctors selecting devices for military patients.

The 2020 Journal of Forensic and Investigative Accounting analysis, A Forensic Accountant’s Guide to the Most Potent Federal Laws Used Against Healthcare Fraud, explains that kickback arrangements can involve cash or benefits in kind exchanged for purchasing or recommending items paid for by federal programs.

An insider who knows why a physician received a paid assignment, what work it required and which customer account it served can explain that relationship from inside the business.

Professional Payments in Other Device Cases

St. Jude Medical’s study-payment settlement concerned allegations that post-market studies and a device registry served as vehicles for paying physicians to select its pacemakers and defibrillators. The government said the company collected data, but alleged that the payments were intended to increase device sales. The presence of a named professional activity did not answer what the manufacturer was paying to obtain.

In the Blackstone Medical settlement, the government alleged kickbacks to spinal surgeons through sham consulting agreements, royalty arrangements and research grants, along with travel and entertainment. Those allegations show how professional fees and hospitality can serve the same sales objective through different expense categories.

DePuy Synthes’s overseas implant settlement shows another connection between a physician’s benefit and purchases elsewhere. DePuy admitted providing free implants and instruments for a Massachusetts surgeon’s overseas operations. The government alleged that those benefits induced the surgeon’s use of DePuy products for Medicare and Medicaid patients in Massachusetts. The benefit and the business it allegedly bought could sit in different countries.

What Evidence Is Needed to Prove Fraud?

In a medical device payment case, useful evidence connects the benefit, the physician’s product decision and the government purchase or claim. For the MED-EL pattern, the commercial connection runs from benefits for military specialists through hearing-device selection to Army and Navy purchases.

We examine honoraria agreements and the work behind them alongside travel records, sales communications and purchasing records. The point is to understand who approved the benefit, what the company expected in return and how the device business followed. These are connections we develop with an insider who understands the account and the people making its decisions.

A whistleblower case under the False Claims Act, a qui tam case, can pay 15% to 30% of what the government recovers.

You Know What the Honorarium Bought

If you know why a device company paid a physician or funded a trip, speak to one of our Whistleblower Experts about what the payment bought. We work with you to build your strongest medical device whistleblower case from that inside knowledge and bring in medical device fraud whistleblower lawyers who understand physician payments and government purchases. We stay beside you from the first conversation through the pursuit of a recovery.